Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer
about
Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
Cancer Immunotherapy GSK157293 ...... ive Non-Small Cell Lung Cancer
@en
Cancer Immunotherapy GSK157293 ...... ive Non-Small Cell Lung Cancer
@nl
type
label
Cancer Immunotherapy GSK157293 ...... ive Non-Small Cell Lung Cancer
@en
Cancer Immunotherapy GSK157293 ...... ive Non-Small Cell Lung Cancer
@nl
prefLabel
Cancer Immunotherapy GSK157293 ...... ive Non-Small Cell Lung Cancer
@en
Cancer Immunotherapy GSK157293 ...... ive Non-Small Cell Lung Cancer
@nl
P1050
P3098
NCT00455572